NovaBridge Biosciences (NBP) Research & Development (2019 - 2025)
NovaBridge Biosciences' Research & Development was $55.66 million in Q4 2025, up 823.0% from $6.03 million a year earlier.
Powered by 
Analysis
NovaBridge Biosciences (NBP) Research & Development (2019 - 2025) Analysis & Trends
For FY2025, Research & Development at NovaBridge Biosciences came in at $62.91 million, up 189.0% from FY2024.
- Research & Development shows a five-year compound annual growth rate of -16.1% (FY2020 to FY2025).
- In earlier years, Research & Development was $21.77 million in FY2024 (+1.5%), $21.45 million in FY2023 (-4.9%), $22.55 million in FY2022 (-88.2%) and $190.34 million in FY2021 (+26.1%).
- The Q4 2025 figure marks the highest quarterly Research & Development in data going back to Q3 2019.
- Compared with a year earlier, Research & Development was higher in two of the last seven quarters, with growth averaging 93.3%.
- Per Business Quant data, NBP's Research & Development in the three quarters before Q4 2025 was $3.18 million (Q3 2025), $3.29 million (Q2 2025) and $777,000 (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.25 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 4.65 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 2.57 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 4.54 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 3.89 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 2.11 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.61 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 3.02 Bn |
| 10 | NovaBridge Biosciences | 99.23 Mn | -696.35 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 55.66 Mn |
| Sep 30, 2025 | 3.18 Mn |
| Jun 30, 2025 | 3.29 Mn |
| Mar 31, 2025 | 777,000.00 |
| Dec 31, 2024 | 6.03 Mn |
| Sep 30, 2024 | 4.48 Mn |
| Jun 30, 2024 | 5.20 Mn |
| Mar 31, 2024 | 6.06 Mn |
| Dec 31, 2023 | 8.16 Mn |
| Sep 30, 2023 | 5.09 Mn |
| Jun 30, 2023 | 4.29 Mn |
| Dec 31, 2020 | 43.19 Mn |
| Sep 30, 2020 | 37.01 Mn |
| Dec 31, 2019 | 37.18 Mn |
| Sep 30, 2019 | 44.70 Mn |
API Access
NovaBridge Biosciences Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=NBP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "NBP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=NBP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();